From: Development and validation of a new patient experience tool in patients with serious illness
Characteristic | Overall (N = 607) | Development Cohort (N = 304) | Validation Cohort (N = 303) | P-Valuea | |||
---|---|---|---|---|---|---|---|
N | Mean ± SD/% | N | Mean ± SD/% | N | Mean ± SD/% | ||
Age, years | 607 | 74 ± 13 | 304 | 74 ± 12 | 303 | 74 ± 13 | 0.915 |
Comorbidity Scoreb | 564 | 5 ± 2 | 280 | 5 ± 2 | 284 | 5 ± 2 | 0.745 |
Utilizationc | |||||||
 ED Visits | 607 | 2 ± 2 | 304 | 2 ± 2 | 303 | 2 ± 3 | 0.963 |
 Inpatient Days | 607 | 5 ± 6 | 304 | 4 ± 6 | 303 | 5 ± 6 | 0.926 |
 ICU Days | 607 | 1 ± 3 | 304 | 0 ± 3 | 303 | 1 ± 4 | 0.285 |
Male | 306 | 50% | 149 | 49% | 157 | 52% | 0.490 |
Married or Living with Partner | 286 | 47% | 140 | 46% | 146 | 48% | 0.599 |
Caucasian | 576 | 95% | 291 | 96% | 285 | 94% | 0.352 |
Highest Level of Education | Â | Â | Â | Â | Â | Â | 0.232 |
 Non-Graduate, H.S. or GED | 189 | 31% | 99 | 33% | 90 | 30% |  |
 Some College to 4-year Graduate | 283 | 47% | 148 | 49% | 135 | 45% |  |
 Graduate or Professional School | 123 | 20% | 52 | 17% | 71 | 23% |  |
 Unknown | 12 | 2% | 5 | 2% | 7 | 2% |  |
Participant Location at Baseline | Â | Â | Â | Â | Â | Â | 0.539 |
 Home | 528 | 87% | 269 | 88% | 259 | 85% |  |
 Assisted Living | 58 | 10% | 26 | 9% | 32 | 11% |  |
 Nursing Home | 21 | 3% | 9 | 3% | 12 | 4% |  |
Primary Diagnosis | Â | Â | Â | Â | Â | Â | 0.485 |
 Heart Failure | 426 | 70% | 220 | 72% | 206 | 68% |  |
 Cancer | 118 | 19% | 54 | 18% | 64 | 21% |  |
 Dementia | 63 | 10% | 30 | 10% | 33 | 11% |  |